ARCHIVES

Biotech Firm Plans Custom Clinical trials In USSR for Drug Firms

This article is from The Cancer Letter archive.

Vol. 15 No. 33 | August 18, 1989

Download PDF Visit The Full Archive

Related Articles

Broder Responds To AACR Proposal, Cites Congressional ‘Commitment’

December 6, 1991

Senate Committee Approves Additional $400 Million For NCI, $275 Million For FDA.

May 16, 2008

In Brief: Cancer Prevention Fellowship Program Application Sought; Grant Funds Available

March 18, 1994

In Brief: Zubrod “One Person Who Made The Difference” In Drug Program, DeVita Says in Center’s 25th

July 27, 1984

Imaging Technique Identifies Consequences Of Mutation

February 24, 2012

Smoking, Drinking Factors Affect Adherence to Preventive Regimen

September 30, 2011